Winnipeg
Canada
15
2025-11-25
The entities that hold a legal rights for patent applications filed by inventor WILLIAMS Mark:
Mark WILLIAMS from Winnipeg, CA has applied for patents for these inventions. The list has both pending applications and granted patents:
Use of glutamate 2B receptor antagonists and sigma receptor agonists as antitussives
#2 | 2025-06-05ANTI-CANCER N-TERMINAL FC CONJUGATED IMMUNOTHERAPEUTICS
#3 | 2024-04-18DMT SALTS AND THEIR USE TO TREAT BRAIN INJURY
#4 | 2022-12-01Use of Glutamate 2B Receptor Antagonists and Sigma Receptor Agonists as Antitussives
#5 | 2022-04-21COMPOSITIONS AND METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
#6 | 2021-09-23COMPOUNDS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND METHODS THEREOF
#7 | 2021-09-23Compositions and methods for treating non-alcoholic steatohepatitis
#8 | 2021-08-26Use of repirinast in the prophylaxis or treatment of renal fibrosis or kidney disease
#9 | 2012-09-06TISSUE KALLIKREIN FOR THE TREATMENT OF HUNTINGTON'S DISEASE
#10 | 2012-08-09TISSUE KALLIKREIN FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER
#11 | 2012-03-22TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC Beta-CELL DYSFUNCTION AND FOR Beta-CELL PROLIFERATION
#12 | 2010-09-09Tissue kallikrein for the treatment of diseases associated with amyloid protein
#13 | 2010-01-14METHODS OF DIAGNOSIS AND TREATMENT FOR METABOLIC DISORDERS
#14 | 2009-12-31COMPOSITIONS CONTAINING (S)-BETHANECHOL AND THEIR USE IN THE TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES, GLUCOSE INTOLERANCE AND RELATED DISORDERS
#15 | 2009-06-25THERAPEUTIC USES OF GLANDULAR KALLIKREIN
3126016 ⎘